Seatbelts in CAR therapy: How Safe Are CARS?

T-cells genetically redirected with a chimeric antigen receptor (CAR) to recognize tumor antigens and kill tumor cells have been infused in several phase 1 clinical trials with success. Due to safety concerns related to on-target/off-tumor effects or cytokine release syndrome, however, strategies to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kentaro Minagawa, Xiaoou Zhou, Shin Mineishi, Antonio Di Stasi
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2015-05-01
Col·lecció:Pharmaceuticals
Matèries:
chimeric antigen receptor
suicide gene
safety switch
adoptive immunotherapy
cell therapy
Accés en línia:http://www.mdpi.com/1424-8247/8/2/230
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars